Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102153609B details a silica gel catalyst method for 6-methylene monoester, offering 88.2% yield and stable content for pharmaceutical supply chains.
Patent CN101052619A details an improved industrial process for preparing 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methylpyridine-2-carboxamide tosylate, offering significant supply chain and cost advantages.
Advanced synthesis of MMP inhibitors via novel Friedel-Crafts and Sonogashira coupling. Cost-effective manufacturing for high-purity pharmaceutical intermediates.
Novel acid-catalyzed esterification method for flurbiprofen derivatives offers cost reduction and scalable manufacturing for pharmaceutical intermediates supply chains.
Novel asymmetric synthesis of (3R)-3-tertbutyldimethylsiloxy-6-dialkoxyphosphono-5-oxo-tertbutyl hexanate via chiral resolution-free route for high-purity statin production.
Novel resolution method ensures high purity acetate salt stability for scalable API manufacturing and significant cost reduction in production.
Patent CN111620798A reveals a catalyst-free one-pot synthesis for high-purity olefin intermediates, offering significant cost reduction and supply chain reliability for global manufacturers.
Novel whole-cell method for L-menthol synthesis offers high ee and cost efficiency. Reliable supplier for flavor and fragrance intermediates with scalable green chemistry.
Patent CN1217930C details a novel route for indole derivatives. Enhances yield and stereocontrol for cholesterol inhibitors. Reliable supply chain solution.
Patent CN105440076A details a mild esterification process for tenofovir disoproxil fumarate offering high purity and significant cost reduction in API manufacturing.
Patent CN106366089B reveals a heavy-metal-free route for high-purity isoindoline derivatives ensuring cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN105669606B details a novel CDI-mediated route for high-optical-purity intermediates. This method ensures stable supply and cost reduction in pharmaceutical intermediates manufacturing without Grignard reagents.
Patent CN1495164A details a Rh-catalyzed route to chiral lactones. Offers high ee and scalable process for MMP inhibitor intermediates.
Patent CN108840838B reveals stable nickel catalyst for 1,1-diarylethane synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN1930112A reveals a Lewis acid-catalyzed route for high-purity quinolone intermediates, offering significant cost reduction and scalable manufacturing advantages.
Patent CN114592027A reveals a novel two-step method for Tauroursodeoxycholic Acid production, offering significant cost reduction in API manufacturing and high-purity outcomes.
Patent CN112409137B reveals inorganic base assisted catalysis for high-purity BINOL. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable methods.
Patent CN104844554B reveals alkali-free synthesis for high-purity Nebivolol intermediates. Enhances supply chain reliability and reduces purification costs significantly.
Patent CN116376872A reveals high-efficiency esterase mutants for (S)-3-cyclohexene-1-carboxylic acid, offering cost reduction and scalable biocatalysis for anticoagulant manufacturing.
Patent CN1438985A details a stereoselective route to gabapentin analogs using chiral enones, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.